HuGE Literature Finder
Records
1
-
6
Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naïve non-small cell lung carcinoma. Oncology letters 2020 5 19 (6): 4169-4176. Yamaura Takumi, Muto Satoshi, Mine Hayato, Takagi Hironori, Watanabe Masayuki, Ozaki Yuki, Inoue Takuya, Fukuhara Mitsuro, Okabe Naoyuki, Matsumura Yuki, Hasegawa Takeo, Osugi Jun, Hoshino Mika, Higuchi Mitsunori, Shio Yutaka, Suzuki Hiroyu |
Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target. International journal of molecular sciences 2018 10 19 (10): . Hung Chin-Sheng, Wang Sheng-Chao, Yen Yi-Ting, Lee Tzong-Huei, Wen Wu-Che, Lin Ruo-K |
Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population. Lung cancer (Amsterdam, Netherlands) 2011 Jul 73 (1): 32-7. Ma Hongxia, Chen Jiaping, Pan Shiyang, Dai Juncheng, Jin Guangfu, Hu Zhibin, Shen Hongbing, Shu Yongqi |
Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer. Journal of translational medicine 2010 9 8 86. Castro Mónica, Grau Laura, Puerta Patricia, Gimenez Liliana, Venditti Julio, Quadrelli Silvia, Sánchez-Carbayo Mar |
DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type. Lung cancer (Amsterdam, Netherlands) 2009 12 69 (2): 172-9. Hawes Stephen E, Stern Joshua E, Feng Qinghua, Wiens Linda W, Rasey Janet S, Lu Hiep, Kiviat Nancy B, Vesselle Hube |
DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 3 17 (3): 645-54. Feng Qinghua, Hawes Stephen E, Stern Joshua E, Wiens Linda, Lu Hiep, Dong Zhao Ming, Jordan C Diana, Kiviat Nancy B, Vesselle Hube |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: